MedPath

Assessment of Fatty Liver with Thermo-acoustic Device

Recruiting
Conditions
NAFLD
Non-alcoholic Steatohepatitis
Fatty Liver Disease
NASH
Non-alcoholic Fatty Liver
Non-Alcoholic Fatty Liver Disease
Fatty Liver
Interventions
Diagnostic Test: Thermo-acuostic image acquisition of liver
Diagnostic Test: MRI-PDFF estimation of hepatic fat
Registration Number
NCT04302051
Lead Sponsor
Medical College of Wisconsin
Brief Summary

The study will evaluate the accuracy of hepatic steatosis estimation by thermo-acoustic ultrasound with estimation by MRI-PDFF (Proton Density Fat Fraction) . It will also evaluate the sensitivity of this device in the diagnosis of fatty liver.

Detailed Description

Patients with either known or presumed diagnosis of non-alcoholic fatty liver disease who meets eligibility criteria will be included in the study. They will have imaging done to estimate hepatic steatosis by two modalities (MRI - PDFF and thermo-acoustic ultrasound). The estimation obtained by thermo-acoustic ultrasound will be compared with MRI results for accuracy of estimation by the thermo-acoustic ultrasound device. The study will also evaluate the sensitivity of the thermo-acoustic ultrasound device if it can diagnose the presence of hepatic steatosis when hepatic fat content is 15% or less by volume.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • patients diagnosed or suspected to have non-alcoholic fatty liver disease
  • Patients 18-70 years of age
  • be able to understand and sign on written informed consent
  • able to undergo ultrasound and MRI examinations
Exclusion Criteria
  • any metal or electronic implants including but not limited to pacemakers, clips, hips
  • known history of pregnancy or becoming pregnant during study period
  • unable to understand and sign on written informed consent
  • intolerant to ultrasound and/or MRI examinations

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Study GroupThermo-acuostic image acquisition of liverThe hepatic fat estimation will be performed on the same subjects with the use of the thermo-acoustic device and by MRI-PDFF. The data obtained from the two estimations will be compared.
Study GroupMRI-PDFF estimation of hepatic fatThe hepatic fat estimation will be performed on the same subjects with the use of the thermo-acoustic device and by MRI-PDFF. The data obtained from the two estimations will be compared.
Primary Outcome Measures
NameTimeMethod
Correlation of hepatic fat estimation by the thermo-acoustic device with MRI-PDFF techniqueone year

The study evaluates if the new thermo-acoustic device can accurately estimate the hepatic fat content among patients with non-alcoholic fatty liver disease to the currently approved method using MRI-PDFF scan.

Secondary Outcome Measures
NameTimeMethod
Evaluate the sensitivity of the thermo-acoustic device in the diagnosis of hepatic steatosis.One year

Evaluate the sensitivity of the thermo-acoustic device in diagnosis presence of hepatic steatosis among patients with MRI-PDFF finding of more than 15% hepatic steatosis

Evaluate the best and ideal number of the anatomical site for thermo-acoustic evaluation of liverOne year

The study evaluates the number of estimation required and the appropriate anatomical site to evaluate the liver to obtain best results

Trial Locations

Locations (1)

Froedtert Hospital

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath